Alistair Roddick

3.8k total citations · 2 hit papers
14 papers, 770 citations indexed

About

Alistair Roddick is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Alistair Roddick has authored 14 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Surgery. Recurrent topics in Alistair Roddick's work include Diabetes Treatment and Management (5 papers), Diabetes Management and Research (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Alistair Roddick is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diabetes Management and Research (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Alistair Roddick collaborates with scholars based in United Kingdom, United States and Italy. Alistair Roddick's co-authors include Sean L. Zheng, Matthew Shun‐Shin, Karim Meeran, Nick Oliver, Dárrel P. Francis, James D. Stefaniak, Fiona T.S. Chan, Apexa Kuverji, William G. Herrington and Alexa Wonnacott and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Alistair Roddick

13 papers receiving 754 citations

Hit Papers

Association of Aspirin Use for Primary Prevention With Ca... 2018 2026 2020 2023 2019 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events
    2019 360 citations Sean L. Zheng, Alistair Roddick JAMA profile →
  2. Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
    2018 283 citations Sean L. Zheng, Alistair Roddick et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alistair Roddick United Kingdom 6 360 288 225 131 129 14 770
Sean L. Zheng United Kingdom 11 322 0.9× 480 1.7× 237 1.1× 145 1.1× 126 1.0× 27 983
Giulia Ferrannini Sweden 13 408 1.1× 208 0.7× 206 0.9× 217 1.7× 79 0.6× 49 695
Walter Massón Argentina 15 285 0.8× 251 0.9× 317 1.4× 144 1.1× 38 0.3× 127 904
Kristin Ohneberg Germany 6 538 1.5× 143 0.5× 291 1.3× 222 1.7× 60 0.5× 10 692
Antonio Nicolucci Italy 11 289 0.8× 170 0.6× 185 0.8× 321 2.5× 61 0.5× 16 881
Heinz Drexel Austria 17 238 0.7× 454 1.6× 255 1.1× 173 1.3× 26 0.2× 51 1.2k
Jie Qin United States 13 404 1.1× 756 2.6× 570 2.5× 82 0.6× 36 0.3× 29 1.2k
Geneviève Mulak France 16 133 0.4× 771 2.7× 187 0.8× 198 1.5× 38 0.3× 27 1.1k
Clint Hurst United States 2 383 1.1× 122 0.4× 107 0.5× 101 0.8× 50 0.4× 2 634

Countries citing papers authored by Alistair Roddick

Since Specialization
Citations

This map shows the geographic impact of Alistair Roddick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Roddick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Roddick more than expected).

Fields of papers citing papers by Alistair Roddick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Roddick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Roddick. The network helps show where Alistair Roddick may publish in the future.

Co-authorship network of co-authors of Alistair Roddick

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Roddick. A scholar is included among the top collaborators of Alistair Roddick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Roddick. Alistair Roddick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Baigent, Colin, Alistair Roddick, & Carlo Patrono. (2025). Estimating the long-term effects of aspirin for primary prevention. European Heart Journal. 46(42). 4423–4425. 1 indexed citations
2.
Herrington, William G., Rebecca J. Sardell, Alistair Roddick, et al.. (2025). Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis. The Lancet Diabetes & Endocrinology. 13(12). 1003–1014. 1 indexed citations
3.
Roddick, Alistair, Alexa Wonnacott, David R. Webb, et al.. (2023). UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE. BMC Nephrology. 24(1). 310–310. 37 indexed citations
4.
5.
Kaura, Amit, Alistair Roddick, Ben Glampson, et al.. (2022). The prognostic significance of troponin level in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study). European Heart Journal. 43(Supplement_2). 1 indexed citations
6.
Roddick, Alistair, et al.. (2022). Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis. SHILAP Revista de lepidopterología. 4(1). 291–293. 3 indexed citations
7.
Staplin, Natalie, Alistair Roddick, Jonathan Emberson, et al.. (2021). Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials. EClinicalMedicine. 41. 101163–101163. 41 indexed citations
8.
Zheng, Sean L. & Alistair Roddick. (2019). Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events. JAMA. 321(3). 277–277. 360 indexed citations breakdown →
9.
Zheng, Sean L., Alistair Roddick, Matthew Shun‐Shin, et al.. (2018). Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes. JAMA. 319(15). 1580–1580. 283 indexed citations breakdown →
10.
11.
Roddick, Alistair, Fiona T.S. Chan, James D. Stefaniak, & Sean L. Zheng. (2017). Discontinuation and non-publication of clinical trials in cardiovascular medicine. International Journal of Cardiology. 244. 309–315. 26 indexed citations
12.
13.
Zheng, Sean L., Alistair Roddick, & Salma Ayis. (2017). Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients. Diabetes and Vascular Disease Research. 14(5). 400–406. 12 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sean L. Zheng Breakdown of academic impact, for papers by Giulia Ferrannini Breakdown of academic impact, for papers by Walter Massón Breakdown of academic impact, for papers by Kristin Ohneberg Breakdown of academic impact, for papers by Antonio Nicolucci Breakdown of academic impact, for papers by Heinz Drexel Breakdown of academic impact, for papers by Jie Qin Breakdown of academic impact, for papers by Geneviève Mulak Breakdown of academic impact, for papers by Clint Hurst
Rankless by CCL
2026